You're contacting media contact of this press release

Title: CoreAge Rx Launches -NAD+ Injectable Therapy to Support Cellular Energy, Cognitive Function, and Healthy Aging

Wichita Falls, TX, United States, 24th Apr 2026 - CoreAge Rx, a telehealth platform focused on medically guided wellness and metabolic support, has announced the launch of its NAD+ Injectable, a new therapy designed to support cellular energy, cognitive performance, and healthy aging through direct systemic delivery of Nicotinamide Adenine Dinucleotide (NAD+).The newly introduced NAD+ Injectable is positioned as part of a broader “brain + body energy protocol,” offering patients a structured approach to addressing age-related declines in cellular function. The therapy is administered via intramuscular or subcutaneous injection, allowing for rapid absorption and systemic availability.NAD+ is a coenzyme naturally present in every cell of the body and plays a critical role in energy metabolism, DNA repair, and mitochondrial function. As NAD+ levels decline with age, individuals may experience fatigue, reduced cognitive clarity, inflammation, and metabolic inefficiencies. CoreAge Rx’s injectable formulation is designed to address these changes by delivering NAD+ directly into the bloodstream, bypassing digestive limitations and enabling efficient utilization at the cellular level.According to the company, the injectable format supports both systemic and neurological rejuvenation, making it a viable option for individuals seeking enhanced mental clarity, improved stamina, and support for long-term cellular health.Expanding Access to Advanced Longevity SupportThe launch of NAD+ Injectable reflects CoreAge Rx’s continued focus on expanding access to physician-guided therapies through a fully digital care model. Patients can complete an online health assessment, which is reviewed by licensed physicians before any treatment is approved. Once prescribed, therapies are fulfilled a...

This press release is issued by King Newswire